Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 11634 in healthy male volunteers
NCT02214914Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of BI 11634 in thromboembolism (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Number of subjects with adverse events at 10 days, Number of subjects with clinically significant findings in vital signs at 10 days and 3 more. Started Nov 2006; status: completed.
02
Drugs
BI 11634
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02214914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214914.